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3':5'-Adenosine monophosphate and N6-2'-0-dibutyryl adenosine 3':5'-monophosphate monosodium salts were purchased from Sigma and prepared for human use as follows: the dry powder was dissolved in a 0.9% solution of NaCl to a concentration of 5 mg/ml and adjusted to p H 7.4 with 0.01 N of N a O H . The solutions were sterilized by filtration on Millipore filters. L,-vasopressin was purchased from Sandoz and diluted in 0.9% NaCl
In nephrogenic diabetes insipidus, the basic defect responsible for solution. he antidiuretic activity of the c-AMP preparation was vasopressin resistance presumably is located beyond the intracelluestablished by a single injection in one 10-month-old control lar c-AMP formation. DB c-AMP. might diminish the net reab-patient, a mentally retarded, physically healthy infant without any sorption of water and solutes in the proximal renal tubule. abnormality in renal function. The biologic activity of both the c-AMP and DB c-AMP preparation was shown by their effects on blood glucose, plasma growt'h hormone, and N E F A in one patient. c-AMP is the second messenger of many hormones including the antidiuretic hormone (ADH) (15) . Therefore, the administration of exogenous c-AMP mimics the action of the hormone, causing antidiuresis in normal and vasopressin-deficient subjects (I I).
The present investigation was undertaken to study the effect of intravenously injected c-AMP and of its dibutyryl derivative (DB c-AMP) on diuresis (V), urine osmolality (U,,,) osmolar clearance (C,,,), and free water clearance (CH20) in six patients with nephrogenic diabetes insipidus (NDI).
PATIENTS
The six patients have nephrogenic diabetes insipidus (Table I) . The first two are unrelated girls. The third patient, a boy, is the child of a consanguinous marriage between cousins. The three other cases are brothers. All six children showed no other abnormality than their concentration inability which was uninfluenced by vasopressin. Their glomerular filtration, estimated by endogenous creatinine clearance, was normal.
METHODS, PATIENTS, AND SPECIAL STUDIES SPECIAL STUDIES METHODS
AC, as the first patient with N D I to be submitted to our c-AMP and DB c-AMP investigations, was studied in more detail. All children were studied after informed consent of the parents Protocol I. Alternating intravenous injections of c-AMP and had been obtained. An intravenous infusion with 5% glucose or pitressin at hourly intervals. 0.9% sodium chloride solution was maintained throughout each
In patient A C , after a control period of 1 hr, 6 mg/kg body wt test at a rate of 0.5-2 ml/min. The volume of infusate expressed in c-AMP was injected slowly. One hour later, 2 units of pitressin milliliters per minute per square meter varied between 1.35 and were given by i.v. injection. After the same interval of 1 hr, c-AMP 1.88 in the individual patients with a mean of 1.58. Urine was injection was repeated at a dose of 10 mg/kg, followed by 1 unit obtained in 15-min portions by an indwelling catheter. Plasma pitressin. In the five other patients with N D I , pitressin was injected samples for measurement of osmolality (P,,,) were taken every only once and at a dose of 0.1 unit. hour. The patients were not fasted and during the test they were Protocol II. Infusion of c-AMP and DB c-AMP. After a control offered water hourly in amounts equal to the urinary output in the period of 45-60 min, 0.5 mg/kg/min c-AMP was perfused during preceding clearance period. They regularly took less than these 45-60 min, followed by an infusion of 0.2 mg/kg/min of DB amounts and on the whole, the individual water balances remained c-AMP during the same period of time. Both periods were unchanged up to the start of the last clearance period. The U,,, separated by a wash-out time of 30 min. This experiment was done was measured as well as its volume which was expressed in in the six N D I patients. In patient A C , blood glucose, NEFA, and milliliters per minute (V). C,,, and CHZ0 were calculated according G H were followed at 15-min intervals.
to the equations: C,,, = (U,,, x V)/P,,, and CHZo = V -COSm. Protocol III. Injection of DB c-AMP, Aminophyllin, and A Knauer osmometer was used to determine Po,, and U,,,. Blood Association of c-AMP and Aminophyllin. After a 30-min control 509 period, 5 mg/kg DB c-AMP and 3 mg/kg aminophyllin were injected consecutively at I-hr intervals. After the same interval, both c-AMP, 15 mg/kg, and aminophyllin, 3 mg/kg, were injected simultaneously. This protocol was applied only to patient AC.
RESULTS

PROTOCOL I
The results of protocol I are shown in Figure 1 and in Table 2 . There is no indication of any clear-cut antidiuretic effect either by the two doses of c-AMP, or by pitressin. On the contrary, c-AMP at a dose of 10 mg/kg is associated with a rise in urinary volume in four patients out of the six. Throughout the successive test periods, there are only minor variations in creatinine excretion.
PROTOCOL I1
The results obtained by applyingprotocol 1 1 are shown in Figure  2 and in Table 3 .
The biological activity of the infused cyclic nucleotides is shown in patient AC (Fig. 2) by the changes in serum NEFA, plasma GH, and blood glucose known to occur during the administration of c-AMP and DB c-AMP (12, 13 ). An antidiuresis is only observed in patient M F and to a lesser degree in patient AC under the influence of c-AMP, but is not reproduced during DB c-AMP infusion. In the other patients, the effect of c-AMP on urinary volume is negligible. The infusion with DB c-AMP, on the other hand, results in a rise of urinary volume in all patients. As during protocol I, the creatinine excretions remain unchanged.
PROTOCOL I11
The results are presented in Table 4 . There was no antidiuresis during the whole procedure. On the contrary, urinary volumes rose steadily together with C,,, and CH,O. Creatinine excretion remained unchanged. The exact mechanism by which c-AMP changes the permeability of the tubular membrane is unknown. It has been assumed (7) that c-AMP activates a specific protein kinase. This in turn catalyzes the phosphorylation of a membrane protein, bringing about a change in the structure of the membrane and enhancing its permeability to water. Accordingly, the effectuation of normal vasopressin activity would involve a chain of biochemical processes. It seems useful to subdivide the overall mechanism into two major steps: (I) hormone-stimulated formation of c-AMP and (2) c-AMP-initiated increase of membrane permeability to water. N D I is a so-called pseudo-endocrine disorder, i.e., a disease in which there is no hormone deficit but an end-organ unresponsiveness to the hormone, in this case ADH. Theoretically, N D I could result from a defect in either of both steps of vasopressin action. A defect in the first step could result either from an anomaly of the cellular membrane receptor or from the inactivity of adenylcyclase. In both cases, one would expect exogenous c-AMP to promote antidiuresis in this disease. Our studies are clearly not in favor of this first hypothesis.
In We found the same seemingly paradoxical effect of DB c-AMP together with a definite rise in the urinary volumes in our six patients. At the dosages used, especially in protocol I I , the differences between c-AMP and DB c-AMP are unmistakable. The effect of DB c-AMP cannot be attributed to changes in the glomerular filtration rate, since the creatinine excretion remains unchanged during the several test periods. Neither did overhydration play a role: the patients' water balances were roughly in equilibrium at the beginning of the DB c-AMP infusion. There- For explanation of data, see footnote I of Table 2 .
fore, one might postulate that at least in patients with NDI, DB c-AMP diminishes the water reabsorption at the level of the proximal renal tubule. Such an effect would indeed account for the observed changes in V, CHIO, and C,,,.
It is noteworthy that a diuretic effect combined with stable creatinine excretion was also the salient feature observed in protocol III. This indicates that in NDI patients aminophyllin does no! restore the antidiuretic effect of c-AMP observed in normal individuals.
Jones et al. (10) found that c-AMP transiently reduced urinary output in two of three patients with NDI. A similar effect was noted but only irregularly in two of our six patients. It was, however, rather mild, so that the changes observed could have been spontaneous ones. Avery's and our results would indicate that the pathogenesis of NDI is located beyond c-AMP formation and consists of a defect in the second step of vasopressin action. However, experiments of Fichman and Brooker ( 8 ) are at variance with this "second step hypothesis." These authors observed a deficient urinary c-AMP excretion after infusion of pitressin in N D I patients. They concluded therefore that the pathogenesis of N D I is analogous to that of pseudohypoparathyroidism (PHP). P H P is indeed an example of a pseudoendocrine disorder in which a first stcp dcfcct is likely to be p r c s e n t . I n patients with PHP, Chase et al. (5) showed a defective excretion of c-AMP in response to parathyroid hormone administration, whereas Bell et al. (2) found that DB c-AMP can reproduce the effect of parathyroid hormone. In contrast to the apparently clear-cut situation in P H P , the deficient renal c-AMP excretion under influence of exogenous A D H on one hand and the inactivity of c-AMP infusions on the other hand is paradoxical in NDI. Concerning these apparently contradictory facts, three remarks require consideration. First, the lack of urinary increase of c-AMP after pitressin administration could be the result of a defective release from the collecting duct cells. This possibility, among others, is put forward by Fichman and Brooker (8) . It would be in keeping with the knowledge that, whatever its pathogenesis, N D I is characterized by a disturbance in the permeability of the cell membrane on the tubular lumenal side, the membrane through which intracellular c-AMP is thought to leak into the urine. The second point is that exogenous c-AMP could be unable to enter the target cells and mimic the effect of the hormone. In that respect, it may be pointed out that, in our studies, c-AMP and DB c-AMP were used in relatively high doses and given both as a single shot and in perfusion. Last, it cannot be excluded that in NDI the intracellular breakdown of c-AMP in the renal tubular cells is so high that the cyclic nucleotide cannot exert its normal activity. This could also explain the low values of urinary c-AMP excretion found to occur in N D I patients after parathyroid hormone administration (8) .
SUMMARY
The administration of c-AMP and DB c-AMP to six children with NDI has failed to yield an antidiuretic effect. From the present study it may be concluded that, at the doses used, neither c-AMP nor its dibutyryl derivative can mimic the action of A D H in NDI as they do in normal subjects. On the contrary, DB c-AMP increases urine volume and C,,, in a very marked way, without changing the creatinine excretion.
